Sign in to fuzzto save your conversations, follow your research and come back anytime.
Gland Pharma
SectorHealthcare
| Metric (₹ crore) | Q4 FY20 | Q1 FY21 | Q2 FY21 | Q3 FY21 | Q4 FY21 | Q1 FY22 | Q2 FY22 | Q3 FY22 | Q4 FY22 | Q1 FY23 | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 635.24 | 884.21 | 831.5 | 859.42 | 887.75 | 1,153.9 | 1,080.47 | 1,063.33 | 1,103.01 | 856.9 | 1,044.4 | 938.29 | 785.01 | 1,208.69 | 1,373.42 | 1,545.16 | 1,537.45 | 1,401.71 | 1,405.83 | 1,384.05 | 1,424.91 | 1,505.62 | 1,486.88 | 1,695.36 | 1,742.79 | 1,800.27 |
| Expenses | 395.38 | 471.59 | 533.8 | 595.19 | 560.08 | 717.62 | 703.87 | 714.41 | 754.66 | 586.98 | 747.55 | 648.72 | 616.59 | 914.74 | 1,049.35 | 1,188.77 | 1,178.8 | 1,137.31 | 1,108.78 | 1,024.1 | 1,077.39 | 1,137.86 | 1,172.99 | 1,260.48 | 1,229.77 | 1,310.9 |
| EBITDA | 239.86 | 412.62 | 297.7 | 264.23 | 327.67 | 436.28 | 376.6 | 348.92 | 348.35 | 269.92 | 296.85 | 289.57 | 168.42 | 293.95 | 324.07 | 356.39 | 358.65 | 264.4 | 297.05 | 359.95 | 347.52 | 367.76 | 313.89 | 434.88 | 513.02 | 489.37 |
| Depreciation | 24.08 | 24.23 | 24.66 | 24.97 | 24.92 | 25.28 | 26.11 | 27.83 | 31.08 | 34.91 | 36.67 | 37.61 | 37.54 | 65.32 | 81.3 | 105.34 | 92.61 | 91.96 | 93.83 | 96.33 | 95.76 | 101.05 | 106.31 | 107.65 | 108.66 | 111.26 |
| EBIT | 215.78 | 388.39 | 273.04 | 239.26 | 302.75 | 411 | 350.49 | 321.09 | 317.27 | 235.01 | 260.18 | 251.96 | 130.88 | 228.63 | 242.77 | 251.05 | 266.04 | 172.44 | 203.22 | 263.62 | 251.76 | 266.71 | 207.58 | 327.23 | 404.36 | 378.11 |
| Interest | 0.47 | 0.47 | 0.76 | 1.16 | 1.02 | 1 | 1.02 | 1.18 | 2.03 | 0.9 | 1.72 | 2.62 | 2.2 | 4.92 | 6.05 | 5.28 | 9.96 | 5.62 | 6.11 | 22.82 | 7.45 | 11.5 | 7.82 | 3.93 | 10.03 | 4.36 |
| Profit Before Tax | 215.31 | 387.92 | 272.28 | 238.1 | 301.73 | 410 | 349.47 | 319.91 | 315.24 | 234.11 | 258.46 | 249.34 | 128.68 | 223.71 | 236.72 | 245.77 | 256.08 | 166.82 | 197.11 | 240.8 | 244.31 | 255.21 | 199.76 | 323.3 | 394.33 | 373.75 |
| Net Profit | 194.79 | 313.59 | 218.86 | 204.11 | 260.41 | 350.65 | 302.08 | 273.03 | 285.9 | 229.17 | 241.24 | 231.95 | 78.68 | 194.1 | 194.08 | 191.86 | 192.42 | 143.76 | 163.53 | 204.69 | 186.54 | 215.48 | 183.68 | 261.48 | 366.68 | 316.96 |
| EPS | 12.57 | 20.24 | 14.12 | 12.83 | 15.93 | 21.41 | 18.37 | 16.62 | 17.4 | 13.93 | 14.65 | 14.08 | 4.78 | 11.79 | 11.78 | 11.65 | 11.68 | 8.73 | 9.93 | 12.42 | 11.32 | 13.08 | 11.15 | 15.87 | 22.26 | 19.23 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 700.94 | 604.93 | 790.77 | 363.97 | 996.8 | 914.73 | 1,031.39 |
| Investing Cash Flow | -760.97 | -1,520.42 | -999.31 | 1,211.19 | -1,749.19 | 1,717.87 | 188.48 |
| Financing Cash Flow | -6.87 | 1,238.46 | 34.9 | 14.92 | -799.42 | -433.48 | -416.97 |
| Net Cash Flow | -66.9 | 322.97 | -173.64 | 1,590.08 | -1,551.81 | 2,199.12 | 802.9 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 3,646.24 | 5,903.24 | 7,157.62 | 7,958.72 | 8,723.84 | 9,150.74 | 10,358 |
| Total Liabilities | 439.8 | 592.84 | 676 | 818.81 | 1,937.4 | 2,074.17 | 2,152.89 |
| Total Assets | 4,086.04 | 6,496.08 | 7,833.62 | 8,777.54 | 10,661.2 | 11,224.9 | 12,510.8 |